Cannabis & Autism
Open Learning
On Demand
49
USD
Online
Focus:
Cannabis
Awarded: Certificate of Completion
Description
Patricia Frye, MD details how both core and coexisting conditions associated with Autistic Spectrum Disorder (ASD) may improve with cannabis medicine. The course also addresses the limitations of pharmaceuticals that are currently FDA approved for autism as well as those that are commonly used but based on anecdotal evidence. Dr. Frye reviews approaches to chemovar profiles, dosing regimens and special considerations when treating ASD in children and young adults.
